Cargando…

Including cannabinoids in the treatment of painful schwannomatosis

A 47‐year‐old man, affected by Schwannomatosis, presented a very severe pain (10/10, NRS) with paroxysmal shooting episodes, allodynia, paresthesia, and dysesthesia; in parallel, the patient had lost weight (from 70 to 49 kg) and experienced fatigue and deep depression. The previous pain prescriptio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iorno, Vittorio, Roberto, Anna, Colantonio, Laura Brigitta, Landi, Laura, Corli, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043707/ https://www.ncbi.nlm.nih.gov/pubmed/29845778 http://dx.doi.org/10.1002/brb3.1011

Ejemplares similares

Scrambler Therapy for the Treatment of Pain in Schwannomatosis
por: Murphy, Tyler, et al.
Publicado: (2022)

Pain correlates with germline mutation in schwannomatosis
por: Jordan, Justin T., et al.
Publicado: (2018)

Polyradiculopathies from Schwannomatosis
por: Jia, Yuxia, et al.
Publicado: (2011)

Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
por: Mansouri, Sheila, et al.
Publicado: (2020)

Schwannomatosis of Cervical Vagus Nerve
por: Abdulla, Faheem Ahmed, et al.
Publicado: (2016)

C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis
por: Farschtschi, Said C., et al.
Publicado: (2020)

Segmental schwannomatosis: characteristics in 12 patients
por: Alaidarous, Abdulqader, et al.
Publicado: (2019)

A rare case of schwannomatosis of the extremities
por: Fodor, Lucian, et al.
Publicado: (2020)

A rare case of penile schwannomatosis presenting with painful nocturnal penile tumescence
por: Tow, Chan Ming, et al.
Publicado: (2022)

Surgical treatment of common peroneal neuropathy in schwannomatosis: illustrative cases
por: North, Robert Y., et al.
Publicado: (2021)

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023)

Segmental schwannomatosis: An uncommon cause of crural monoparesis
por: Cherian, Ajith, et al.
Publicado: (2012)

Vestibular dysfunction in NF2–related schwannomatosis
por: Madhani, Amsal S, et al.
Publicado: (2023)

ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis
por: Evans, D. Gareth, et al.
Publicado: (2022)

Co‐occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1
por: Kehrer‐Sawatzki, Hildegard, et al.
Publicado: (2018)

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020)

Schwannomatosis Involving Peripheral Nerves: A Case Report
por: Kim, Dong Hun, et al.
Publicado: (2006)

Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
por: Algar, E
Publicado: (2012)

Schwannomatosis of the Spinal Accessory Nerve: A Case Report
por: Morshed, Ramin A., et al.
Publicado: (2019)

Left atrial schwannoma in schwannomatosis: a case report
por: Yokoyama, Kenji, et al.
Publicado: (2021)

Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
por: Tamura, Ryota
Publicado: (2021)

Screening of potential novel candidate genes in schwannomatosis patients
por: Perez‐Becerril, Cristina, et al.
Publicado: (2022)

Spinal Schwannomatosis Mimicking Metastatic Extramedullary Spinal Tumor
por: Nurdillah, Idris, et al.
Publicado: (2023)

Correction to: Vestibular dysfunction in NF2–related schwannomatosis
Publicado: (2023)

Cannabinoids in the treatment of pain
por: Kara, Eleana, et al.
Publicado: (2010)

Does Hereditary Neuropathy with Liability to Pressure Palsy Predispose to Schwannomatosis?
por: Grapperon, Aude-Marie, et al.
Publicado: (2014)

A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products
por: Nutt, David J., et al.
Publicado: (2022)

Cannabinoids and Cancer
por: Falasca, Marco, et al.
Publicado: (2021)

Simple schwannomatosis or an incomplete Coffin-Siris? Report of a particular case
por: Bellantoni, G., et al.
Publicado: (2018)

Multiple Lower Extremity Mononeuropathies by Segmental Schwannomatosis: A Case Report
por: Kwon, Na Yeon, et al.
Publicado: (2015)

Spatial Distribution and Long-Term Alterations of Peripheral Nerve Lesions in Schwannomatosis
por: Godel, Tim, et al.
Publicado: (2022)

Laminectomy triggers symptomatic growth of spinal schwannoma in a patient with schwannomatosis
por: Oyama, Takahiro, et al.
Publicado: (2022)

The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
por: Gregory, Grace E, et al.
Publicado: (2023)

The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity
por: Ostrow, Kimberly Laskie, et al.
Publicado: (2019)

The Place of Cannabinoids in the Treatment of Gynecological Pain
por: Sinclair, Justin, et al.
Publicado: (2023)

Cannabinoids: for better and for worse 
por: Thibaut, Florence, et al.
Publicado: (2020)

Role of Cannabinoids in Inflammation
por: Downer, Eric J.
Publicado: (2022)

Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients
por: Apolone, Giovanni, et al.
Publicado: (2006)

SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
por: Rousseau, Guillaume, et al.
Publicado: (2011)

A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis
por: Zhang, Keqiang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gvt0go89e25fbtgqsq8ip07cha